AU3604393A - Novel gene therapies employing antisense constructs - Google Patents

Novel gene therapies employing antisense constructs

Info

Publication number
AU3604393A
AU3604393A AU36043/93A AU3604393A AU3604393A AU 3604393 A AU3604393 A AU 3604393A AU 36043/93 A AU36043/93 A AU 36043/93A AU 3604393 A AU3604393 A AU 3604393A AU 3604393 A AU3604393 A AU 3604393A
Authority
AU
Australia
Prior art keywords
novel gene
antisense constructs
gene therapies
therapies employing
employing antisense
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36043/93A
Inventor
Harris Busch
Rose Busch
Laszlo Perlaky
Yasuo Saijo
Ben Valdez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Original Assignee
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine filed Critical Baylor College of Medicine
Publication of AU3604393A publication Critical patent/AU3604393A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
AU36043/93A 1992-02-18 1993-01-28 Novel gene therapies employing antisense constructs Abandoned AU3604393A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83777192A 1992-02-18 1992-02-18
US837771 1992-02-18

Publications (1)

Publication Number Publication Date
AU3604393A true AU3604393A (en) 1993-09-03

Family

ID=25275366

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36043/93A Abandoned AU3604393A (en) 1992-02-18 1993-01-28 Novel gene therapies employing antisense constructs

Country Status (2)

Country Link
AU (1) AU3604393A (en)
WO (1) WO1993015743A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753432A (en) * 1990-10-19 1998-05-19 Board Of Trustees Of The University Of Illinois Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
WO1993017125A1 (en) * 1992-02-19 1993-09-02 Baylor College Of Medicine Oligonucleotide modulation of cell growth

Also Published As

Publication number Publication date
WO1993015743A1 (en) 1993-08-19

Similar Documents

Publication Publication Date Title
AU1768192A (en) Rna delivery vector
AU3972893A (en) Gene therapy using the intestine
AU8116494A (en) Gene signature
AU6625296A (en) Dna constructs
AU3927493A (en) Improved enzyme electrodes
AU699706C (en) Improved vectors for gene therapy
AU2956092A (en) Novel plant gene
AU5568694A (en) Stable oligonucleotides
AU3157389A (en) Genetic manipulation
AU9094991A (en) Triplex-forming oligomers containing modified bases
GB9306386D0 (en) Gene expression
EP0739983A3 (en) Gene encoding lacto-n-biosidase
AU5590394A (en) Transglutaminase gene
AU5974194A (en) Oligonucleotides with rna cleavage activity
AU1052792A (en) Gene synthesis
AU3604393A (en) Novel gene therapies employing antisense constructs
AU6679094A (en) Genetic stabilizing elements
AU4018393A (en) Serum-free cell culture medium
AU2896295A (en) Alpha-lactalbumin gene constructs
AU9380898A (en) Mammalian circadian rhythm-like gene
AU5582194A (en) Virulence-specific bacterial dna sequence
RU2003663C1 (en) Dessert liqueur
AU4649396A (en) Gene transduction system
AU2387292A (en) Antisense oligonucleotides
AU4425593A (en) New isobutyl-substituted methanesulphonyl-quinolylmethoxyphenyl-cycloalkylacetamides